October 17, 2016 (CNBC)
Arie Belldegrun, Kite Pharma CEO talks to CNBC’s Meg Tirrell about developing cancer immunotherapy drugs with T-cells. Also Belldegrun address the question about pricing the product once it comes to market.
October 17, 2016 (CNBC)
Arie Belldegrun, Kite Pharma CEO talks to CNBC’s Meg Tirrell about developing cancer immunotherapy drugs with T-cells. Also Belldegrun address the question about pricing the product once it comes to market.